Overview
At BioHealth Innovations, we have developed an innovative platform that revolutionizes how medications are delivered in the healthcare sector. Our proprietary drug delivery system utilizes advanced biotechnology to enhance bioavailability and reduce side effects, offering significant benefits for patients suffering from chronic diseases. We have already completed initial testing phases, demonstrating impressive efficacy and safety profiles, garnering interest from healthcare providers and pharmaceutical companies alike. The need for this investment arises from our goal to accelerate our development process, conduct comprehensive clinical trials, and expand our production capabilities. With the global biopharmaceutical market projected to reach $2.4 trillion by 2026, our unique approach positions us to capture a considerable market share and fulfill a critical need in patient care. To date, we have secured partnerships with leading research institutions and completed preliminary trials with promising results. These connections enhance our credibility and provide a solid foundation for growth. We are at a pivotal stage where additional funding will enable us to transition from develo…
Use of funds
The $1,200,000 investment will be allocated as follows:
- $600,000 for conducting extensive clinical trials to validate our drug delivery systems.
- $300,000 for expanding our manufacturing capacity to meet anticipated demand.
- $200,000 for marketing and business development efforts to secure partnerships with major pharmaceutical companies.
- $100,000 for operational expenses and regulatory compliance.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.